{"id":26839,"date":"2021-01-15T11:14:11","date_gmt":"2021-01-15T03:14:11","guid":{"rendered":"http:\/\/biopioneer.com.tw\/?p=26839"},"modified":"2022-07-19T15:14:00","modified_gmt":"2022-07-19T07:14:00","slug":"il-33%e5%a4%9a%e6%a0%aa%e6%8a%97%e9%ab%94-%e8%b2%a8%e8%99%9f5110-50","status":"publish","type":"post","link":"http:\/\/biopioneer.com.tw\/?p=26839","title":{"rendered":"IL-33\u591a\u682a\u6297\u9ad4 | \u8ca8\u865f5110-50"},"content":{"rendered":"

IL-33\u591a\u682a\u6297\u9ad4 | <\/strong>\u8ca8\u865f<\/strong>5110-50<\/a><\/span><\/p>\n

\u7522\u54c1\u63cf\u8ff0:<\/strong> \u4ebaIL-33\u662f\u4e00\u7a2e\u4fc3\u708e\u86cb\u767d(proinflammatory protein)\uff0c\u8207IL-1\u7d30\u80de\u56e0\u5b50\u5bb6\u65cf\u5177\u6709\u7d50\u69cb(structural)\u548c\u529f\u80fd\u7279\u5fb5(functional characteristics)\u3002\u5b83\u901a\u904e\u6fc0\u6d3bNF-\u03baB\u548cMAP\u6fc0\u9176(MAP kinases)\u7684IL-1RL1 \/ ST2\u53d7\u9ad4\u7d50\u5408\u4f75\u767c\u51fa\u4fe1\u865f\u3002IL-33\u8a98\u5c0e\u7522\u751fTH2\u7d30\u80de\u76f8\u95dc\u7684\u7d30\u80de\u56e0\u5b50(TH2 cell related cytokines)\uff0c\u5305\u62ecIL-4\uff0cIL-5\u548cIL-13\uff0c\u4e26\u767c\u63ee\u591a\u7a2e\u708e\u75c7\u76f8\u95dc\u7684\u751f\u7269\u6d3b\u6027\u3002<\/p>\n

\u7a40\u80f1\u7518\u80bd\u904e\u6c27\u5316\u7269\u9176\u6d3b\u6027\u6e2c\u5b9a<\/a> | \u00a0FRAP\u6aa2\u6e2c<\/a> | \u7e3d\u81a0\u539f\u86cb\u767d\u5206\u6790<\/u><\/strong><\/a> | Dopamine\u591a\u5df4\u80fa\u6aa2\u6e2c<\/a> | \u4e09\u9178\u7518\u6cb9\u916f\u5206\u6790<\/a> | Cholesterol Efflux\u81bd\u56fa\u9187\u6392\u51fa\u87a2\u5149\u5206\u6790<\/a> | \u8102\u8cea\u904e\u6c27\u5316\uff08<\/strong>MDA<\/strong>\uff09\u6e2c\u5b9a<\/strong><\/a> | <\/strong>\u652f\u93c8\u6c28\u57fa\u9178<\/strong><\/a> BCAA<\/u><\/strong>\u6aa2\u6e2c<\/u><\/strong><\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Cat # +Size<\/strong><\/td>\n5110-50<\/td>\n<\/tr>\n
Size<\/strong><\/td>\n50 \u00b5g<\/td>\n<\/tr>\n
Antibody Target<\/strong><\/td>\nIL-33<\/td>\n<\/tr>\n
Alternate Name<\/strong><\/td>\nNF-HEV<\/td>\n<\/tr>\n
Host<\/strong><\/td>\nRabbit<\/td>\n<\/tr>\n
Antibody Type<\/strong><\/td>\nPolyclonal<\/td>\n<\/tr>\n
Isotype<\/strong><\/td>\nRabbit IgG<\/td>\n<\/tr>\n
Immunogen<\/strong><\/td>\nE.coli derived Recombinant Human IL-33<\/td>\n<\/tr>\n
Accession #<\/strong><\/td>\nO95760<\/td>\n<\/tr>\n
Gene ID<\/strong><\/td>\n90865<\/td>\n<\/tr>\n
Appearance<\/strong><\/td>\nLiquid<\/td>\n<\/tr>\n
Concentration<\/strong><\/td>\n1 mg\/ml<\/td>\n<\/tr>\n
Formulation<\/strong><\/td>\nA sterile filtered antibody solution in PBS, pH 7.2.<\/td>\n<\/tr>\n
Purification<\/strong><\/td>\nAffinity chromatography<\/td>\n<\/tr>\n
Species Reactivity<\/strong><\/td>\nHuman<\/td>\n<\/tr>\n
Application<\/strong><\/td>\nWestern blot, ELISA, Neutralization, Immunohistochemistry<\/td>\n<\/tr>\n
Positive Control<\/strong><\/td>\nELISA: Recombinant hIL-33 (Cat # 4193)IHC: Human breast malignant ductal adenocarcinoma<\/td>\n<\/tr>\n
Application & Usage<\/strong><\/td>\n1) WB: Use 0.1-0.2 \u00b5g\/ml. The detection limit for recombinant human IL-33 is 1.5-3.0 ng\/lane, under either reducing or non-reducing conditions.
\n2) ELISA: Use 0.5 – 2.0 \u03bcg\/ml (100 \u03bcl\/well antibody solution)
\n3) Neutralization: To yield one-half maxim<\/td>\n<\/tr>\n
Handling<\/strong><\/td>\nThe antibody solution should be gently mixed before use.<\/td>\n<\/tr>\n
Storage Conditions<\/strong><\/td>\n-20 \u00b0C<\/td>\n<\/tr>\n
Shipping Conditions<\/strong><\/td>\nGel Pack<\/td>\n<\/tr>\n
USAGE<\/strong><\/td>\nFor Research Use Only! Not For Use in Humans.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u4e7e\u6d74\u52a0\u71b1\u6c34\u6d74\u69fd<\/strong><\/a>\u00a0|\u00a0 <\/strong>Finnpipette F3 <\/strong>\u5fae\u91cf\u5206\u6ce8\u5668<\/strong><\/a>\u00a0| \u00a0<\/strong>\u8a66\u7ba1\u632f\u76ea\u5668 Vortex Mixer\u00a0<\/strong><\/a>\u00a0|\u00a0 <\/strong>Genereach<\/strong>\u8ff7\u4f60\u578b\u5fae\u91cf\u96e2\u5fc3\u6a5f<\/strong><\/a>\u00a0 |\u00a0\u00a0 <\/strong>ELISA<\/strong>\u5100\u5668<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IL-33\u591a\u682a\u6297\u9ad4 | \u8ca8\u865f5110-50 \u7522\u54c1\u63cf\u8ff0: \u4ebaIL-33\u662f\u4e00\u7a2e\u4fc3\u708e\u86cb\u767d(proinflammato […]<\/p>\n","protected":false},"author":3,"featured_media":459,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[1218],"_links":{"self":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/26839"}],"collection":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26839"}],"version-history":[{"count":1,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/26839\/revisions"}],"predecessor-version":[{"id":26840,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/26839\/revisions\/26840"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/459"}],"wp:attachment":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26839"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}